ADL
WST icon

Asset Dedication LLC’s West Pharmaceutical WST Stock Holding History

Asset Dedication LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22
Closed -$6.05K – 1196
2025
Q4 		$6.05K Hold
22
– – ﹤0.01% 859
2025
Q3 		$5.77K Buy
+22
New +$5.35K ﹤0.01% 890
2024
Q3 		– Sell
-14
Closed -$4.61K – 1256
2024
Q2 		$4.61K Hold
14
– – ﹤0.01% 937
2024
Q1 		$6K Hold
14
– – ﹤0.01% 764
2023
Q4 		$5K Hold
14
– – ﹤0.01% 809
2023
Q3 		$5K Buy
+14
New +$5.41K ﹤0.01% 799

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Asset Dedication LLC's WST Position: Q1 2026 in Review

Asset Dedication LLC sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 22 shares — an estimated $6.05K sold.

Asset Dedication LLC first reported a position in WST in Q3 2023 and held it in 6 quarters. The position peaked at $6.05K in Q4 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Asset Dedication LLC reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Asset Dedication LLC sold 22 West Pharmaceutical shares in Q1 2026, an estimated $6.05K.
  • Asset Dedication LLC first reported a position in West Pharmaceutical in Q3 2023 and held it in 6 quarters.
  • Asset Dedication LLC's West Pharmaceutical position peaked at $6.05K in Q4 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Asset Dedication LLC's 13F filing for Q1 2026, filed 29 May 2026.